. . .

Tag: Cancer Biomarkers Testing

Unlocking Precision Medicine: The Impact of Cancer/Tumor Profiling on Treatment Pathways

The Cancer/Tumor Profiling Market is projected to reach $24.70 billion by 2031 at a CAGR of 10.9% from 2024 to 2031.

The global increase in cancer diagnoses has put considerable strain on healthcare systems, leading to a heightened demand for Read More..